EA200870515A1 - Моноциклические гетероарильные соединения - Google Patents
Моноциклические гетероарильные соединенияInfo
- Publication number
- EA200870515A1 EA200870515A1 EA200870515A EA200870515A EA200870515A1 EA 200870515 A1 EA200870515 A1 EA 200870515A1 EA 200870515 A EA200870515 A EA 200870515A EA 200870515 A EA200870515 A EA 200870515A EA 200870515 A1 EA200870515 A1 EA 200870515A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compounds
- heteroarryl
- monocyclic
- preparation
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
Abstract
Настоящее изобретение относится к соединениям общей формулы (I), вариабельные группы в которой определены в описании изобретения, к их получению и применению.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79847206P | 2006-05-08 | 2006-05-08 | |
US83319106P | 2006-07-25 | 2006-07-25 | |
US92068707P | 2007-03-29 | 2007-03-29 | |
PCT/US2007/011136 WO2007133562A2 (en) | 2006-05-08 | 2007-05-08 | Monocyclic heteroaryl compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200870515A1 true EA200870515A1 (ru) | 2009-06-30 |
Family
ID=38694440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200870515A EA200870515A1 (ru) | 2006-05-08 | 2007-05-08 | Моноциклические гетероарильные соединения |
Country Status (13)
Country | Link |
---|---|
US (3) | US8278307B2 (ru) |
EP (1) | EP2024366B1 (ru) |
JP (1) | JP5273038B2 (ru) |
KR (1) | KR101441365B1 (ru) |
CN (1) | CN103467385B (ru) |
AU (1) | AU2007249926B8 (ru) |
BR (1) | BRPI0710331A2 (ru) |
CA (1) | CA2650273C (ru) |
EA (1) | EA200870515A1 (ru) |
ES (1) | ES2555515T3 (ru) |
IL (1) | IL194678A (ru) |
MX (1) | MX2008014290A (ru) |
WO (1) | WO2007133562A2 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2618513A1 (en) | 2005-08-11 | 2007-02-22 | Ariad Pharmaceuticals, Inc. | Unsaturated heterocyclic derivatives |
KR101436303B1 (ko) | 2005-12-23 | 2014-09-02 | 어리어드 파마슈티칼스, 인코포레이티드 | 비시클릭 헤테로아릴 화합물 |
MX2008014289A (es) | 2006-05-08 | 2008-11-26 | Ariad Pharma Inc | Compuestos heteroarilicos acetilenicos. |
WO2009100536A1 (en) * | 2008-02-15 | 2009-08-20 | Methylgene Inc. | Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
JP5590040B2 (ja) | 2008-11-12 | 2014-09-17 | アリアド・ファーマシューティカルズ・インコーポレイテッド | キナーゼ阻害剤としてのピラジノピラジンおよび誘導体 |
WO2012127030A1 (en) * | 2011-03-23 | 2012-09-27 | Proteosys Ag | Arylpiperazines as neuroprotective agents |
CN103420977B (zh) * | 2012-05-16 | 2016-06-22 | 上海医药集团股份有限公司 | 具有抗肿瘤活性的乙炔衍生物 |
CN103848829B (zh) | 2012-11-28 | 2017-04-12 | 南京圣和药业股份有限公司 | 杂芳基炔烃化合物及其应用 |
CA3022250A1 (en) | 2012-12-12 | 2014-06-12 | Ariad Pharmaceuticals, Inc. | Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride |
US20140343282A1 (en) | 2013-05-16 | 2014-11-20 | Apicore, Llc | Processes for making ponatinib and intermediates thereof |
GB2522226A (en) * | 2014-01-17 | 2015-07-22 | Agency Science Tech & Res | Heteroaryl alkyne derivatives and uses thereof |
AU2015291522B2 (en) | 2014-07-17 | 2018-12-06 | Sunshine Lake Pharma Co., Ltd. | Substituted urea derivatives and pharmaceutical uses thereof |
CN105646361B (zh) * | 2016-02-17 | 2017-12-01 | 吉首大学 | 一种2,4,5‑三芳基咪唑型化合物及其制法和用途 |
EA201991198A1 (ru) | 2016-12-15 | 2020-01-13 | Ариад Фармасьютикалз, Инк. | АМИНОТИАЗОЛЬНЫЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ c-Kit |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9823871D0 (en) | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
UA73492C2 (en) | 1999-01-19 | 2005-08-15 | Aromatic heterocyclic compounds as antiinflammatory agents | |
HN2001000008A (es) | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
DE10021246A1 (de) | 2000-04-25 | 2001-10-31 | Schering Ag | Substituierte Benzoesäureamide und deren Verwendung als Arzneimittel |
IL155196A0 (en) * | 2000-10-05 | 2003-11-23 | Fujisawa Pharmaceutical Co | Benzamide derivatives and pharmaceutical compositions containing the same |
SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
IL159811A0 (en) * | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
US20040110802A1 (en) * | 2002-08-23 | 2004-06-10 | Atli Thorarensen | Antibacterial benzoic acid derivatives |
GB0230089D0 (en) | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
DE10306250A1 (de) | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US20050014753A1 (en) * | 2003-04-04 | 2005-01-20 | Irm Llc | Novel compounds and compositions as protein kinase inhibitors |
AU2004276337B2 (en) | 2003-09-24 | 2009-11-12 | Methylgene Inc. | Inhibitors of histone deacetylase |
ATE415970T1 (de) | 2003-12-24 | 2008-12-15 | Astrazeneca Ab | Pyrimidine mit tie2 (tek) aktivität |
WO2005060969A1 (en) | 2003-12-24 | 2005-07-07 | Astrazeneca Ab | Pyrimidines with tie2 (tek) activity |
EP1756081A1 (en) | 2004-04-07 | 2007-02-28 | Applied Research Systems ARS Holding N.V. | 1,1'-(1,2-ethynediyl)bis-benzene derivatives as ptp 1-b inhibitors |
US7361764B2 (en) * | 2004-07-27 | 2008-04-22 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
GB0502418D0 (en) * | 2005-02-05 | 2005-03-16 | Astrazeneca Ab | Compounds |
US20080194552A1 (en) * | 2005-03-31 | 2008-08-14 | Astrazeneca Ab | Aminopyrimidine Derivatives With Tie2 Inhibiting Activity |
JP2009502734A (ja) | 2005-07-29 | 2009-01-29 | アステラス製薬株式会社 | Lck阻害剤としての縮合複素環 |
CA2618513A1 (en) | 2005-08-11 | 2007-02-22 | Ariad Pharmaceuticals, Inc. | Unsaturated heterocyclic derivatives |
KR101436303B1 (ko) | 2005-12-23 | 2014-09-02 | 어리어드 파마슈티칼스, 인코포레이티드 | 비시클릭 헤테로아릴 화합물 |
CN101490053B (zh) * | 2006-05-08 | 2013-09-11 | 阿里亚德医药股份有限公司 | 单环杂芳基化合物 |
MX2008014289A (es) * | 2006-05-08 | 2008-11-26 | Ariad Pharma Inc | Compuestos heteroarilicos acetilenicos. |
-
2007
- 2007-05-08 CA CA2650273A patent/CA2650273C/en not_active Expired - Fee Related
- 2007-05-08 MX MX2008014290A patent/MX2008014290A/es active IP Right Grant
- 2007-05-08 EP EP07756233.8A patent/EP2024366B1/en not_active Not-in-force
- 2007-05-08 KR KR1020087029946A patent/KR101441365B1/ko active IP Right Grant
- 2007-05-08 JP JP2009509821A patent/JP5273038B2/ja not_active Expired - Fee Related
- 2007-05-08 US US12/227,130 patent/US8278307B2/en not_active Expired - Fee Related
- 2007-05-08 CN CN201310352392.3A patent/CN103467385B/zh not_active Expired - Fee Related
- 2007-05-08 EA EA200870515A patent/EA200870515A1/ru unknown
- 2007-05-08 BR BRPI0710331-0A patent/BRPI0710331A2/pt not_active IP Right Cessation
- 2007-05-08 WO PCT/US2007/011136 patent/WO2007133562A2/en active Application Filing
- 2007-05-08 ES ES07756233.8T patent/ES2555515T3/es active Active
- 2007-05-08 AU AU2007249926A patent/AU2007249926B8/en not_active Ceased
-
2008
- 2008-10-12 IL IL194678A patent/IL194678A/en active IP Right Grant
-
2012
- 2012-09-12 US US13/612,067 patent/US20130005738A1/en not_active Abandoned
-
2017
- 2017-09-08 US US15/699,579 patent/US20170369446A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5273038B2 (ja) | 2013-08-28 |
CN103467385A (zh) | 2013-12-25 |
JP2009536652A (ja) | 2009-10-15 |
US8278307B2 (en) | 2012-10-02 |
IL194678A (en) | 2017-03-30 |
ES2555515T3 (es) | 2016-01-04 |
AU2007249926B2 (en) | 2013-07-04 |
KR20090018942A (ko) | 2009-02-24 |
CN103467385B (zh) | 2016-03-09 |
US20130005738A1 (en) | 2013-01-03 |
EP2024366B1 (en) | 2015-09-16 |
BRPI0710331A2 (pt) | 2012-03-20 |
WO2007133562A2 (en) | 2007-11-22 |
EP2024366A2 (en) | 2009-02-18 |
WO2007133562A3 (en) | 2008-10-02 |
US20090149471A1 (en) | 2009-06-11 |
CA2650273C (en) | 2016-06-07 |
US20170369446A1 (en) | 2017-12-28 |
AU2007249926A1 (en) | 2007-11-22 |
AU2007249926B8 (en) | 2013-11-07 |
KR101441365B1 (ko) | 2014-09-18 |
AU2007249926A8 (en) | 2013-11-07 |
MX2008014290A (es) | 2008-11-26 |
EP2024366A4 (en) | 2011-06-29 |
CA2650273A1 (en) | 2007-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200870515A1 (ru) | Моноциклические гетероарильные соединения | |
EA200870514A1 (ru) | Ацетиленовые гетероарильные соединения | |
EA200870116A1 (ru) | Бициклические гетероарильные соединения | |
EA201000950A1 (ru) | Азолилметилоксираны, их применение, а также содержащие их средства | |
EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
EA201070422A1 (ru) | Производные оксадиазола | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
EA201300242A1 (ru) | Фармацевтические композиции, содержащие замещенные ациланилиды | |
EA201071339A1 (ru) | Фосфорсодержащие производные в качестве ингибиторов киназы | |
EA201270254A1 (ru) | Производные 5-фторпиримидинона | |
EA201270257A1 (ru) | Производные n1-сульфонил-5-фторпиримидинона | |
EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
EA201170288A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
EA201070009A1 (ru) | Производные 7-алкинил-1,8-нафтиридонов, их получение и их применение в терапии | |
EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
EA201171246A1 (ru) | Содержащая трегалулозу композиция, ее получение и применение | |
EA201000550A1 (ru) | Производные тиазола | |
EA201000329A1 (ru) | Циклические депсипептиды | |
BRPI0812222A2 (pt) | Compostos ciclobutenodiona substituídos anti-inflamatórios. | |
DE602006009789D1 (de) | Acetylenderivate | |
EA201290642A1 (ru) | Соединения и способы | |
EA201201406A1 (ru) | Фунгицидные смеси ii, содержащие хиназолины | |
EA201201623A1 (ru) | Лечение диабета 2 типа |